MarketFirst Bank And 4 Other Stocks Have High Sales Growth And An Above 3% Return on EquityViaNews Editorial Team•Jan 3, 2024
MarketDouYu Stock Surges 22% In 5 Sessions: Is It A Buying Opportunity?ViaNews Editorial Team•Jan 3, 2024
MarketNVIDIA And 7 Other Stocks Have High Sales Growth And An Above 3% Return on EquityViaNews Editorial Team•Jan 3, 2024
MarketCherry Hill Mortgage Investment Corporation, ClearBridge Energy MLP Fund, Another 2 Companies Have A High Estimated Dividend YieldViaNews Editorial Team•Jan 3, 2024
MarketTempleton Global Income Fund And 3 Other Stocks Have Very High Payout RatioViaNews Editorial Team•Jan 3, 2024
MarketIntercontinental Exchange And 4 Other Stocks Have High Sales Growth And An Above 3% Return on EquityViaNews Editorial Team•Jan 3, 2024
MarketThe Gabelli Healthcare & Wellness Trust, Nuveen California Select Tax, Another 5 Companies Have A High Estimated Dividend YieldViaNews Editorial Team•Jan 3, 2024
MarketDHT Holdings And 7 Other Stocks Have High Sales Growth And An Above 3% Return on EquityViaNews Editorial Team•Jan 3, 2024
MarketArtificial Intelligence Successfully Predicts Price Trend Of Biogen And AmgenViaNews Editorial Team•Jan 3, 2024
MarketPhysicians Realty Trust And 3 Other Stocks Have Very High Payout RatioViaNews Editorial Team•Jan 3, 2024
MarketStoneCo And 5 Other Stocks Have High Sales Growth And An Above 3% Return on EquityViaNews Editorial Team•Jan 3, 2024
MarketBlackRock Utility And Infrastructure Trust, Main Street Capital Corporation, Another 3 Companies Have A High Estimated Dividend YieldViaNews Editorial Team•Jan 3, 2024
MarketArtificial Intelligence Predicts Next Session's Price Change For NRG Energy, Canadian Imperial Bank Of Commerce, Graham Holdings CompanyViaNews Editorial Team•Jan 2, 2024
MarketInovio Pharmaceuticals Stock Impressive Jump On Tuesday, Outperforms MarketViaNews Editorial Team•Jan 2, 2024
MarketAmerican Public Education Stock Impressive Jump On Tuesday, Outperforms MarketViaNews Editorial Team•Jan 2, 2024
MarketAkerna Corp. And Kintara Therapeutics On The List Of Winners And Losers Of Tuesday's US SessionViaNews Editorial Team•Jan 2, 2024